J Korean Assoc Oral Maxillofac Surg.  2019 Jun;45(3):152-157. 10.5125/jkaoms.2019.45.3.152.

Sedation with dexmedetomidine in elderly patients during dental surgery: a retrospective case series

Affiliations
  • 1Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Fukuoka University, Fukuoka, Japan. miichan@fukuoka-u.ac.jp

Abstract


OBJECTIVES
The number of elderly patients with systemic basal disease requiring invasive dental treatment has increased. Appropriate prediction of surgical invasiveness and combined use of psychosedation are thought to contribute to safe whole-body management. Dexmedetomidine (DEX) exhibits analgesic and anti-anxiolytic properties and causes mild respiratory depression. Studies regarding DEX use in elderly non-intubated patients are scarce. We aimed to use retrospective data to determine an effective dose of DEX to induce adequate sedation in elderly patients undergoing invasive dental surgery under local anesthesia.
MATERIALS AND METHODS
One hundred two patients aged 70 to 96 years were presumably appropriately controlled with sedation. DEX was administered at an initial loading dose of 2.0 to 3.1 µg/kg/hr for 10 minutes. We divided the patients into five groups by age and compared their blood pressures and heart rates.
RESULTS
In all five groups, blood pressure decreased suddenly at approximately 15 and 20 minutes after DEX administration. A marked decrease in blood pressure was noted in patients aged 75 to 79 years.
CONCLUSION
For elderly patients aged 75 years and above, the initial loading dose of DEX needs to be reduced to lower than half that required for young and middle-age adults.

Keyword

Dexmedetomidine; Sedation; Elderly

MeSH Terms

Adult
Aged*
Anesthesia, Local
Blood Group Antigens
Blood Pressure
Dexmedetomidine*
Heart Rate
Humans
Respiratory Insufficiency
Retrospective Studies*
Blood Group Antigens
Dexmedetomidine

Figure

  • Fig. 1 A, B. Transitional changes in mean blood pressure. (Admit: admission time, Pre-sedation: walking into the operating room, DEX IV: immediately before administration of dexmedetomidine, 5 min: 5 minutes after the administration of dexmedetomidine, 10 min: 10 minutes after the administration of dexmedetomidine, LA: immediately after infiltration anesthesia, 15 min: 15 minutes after the administration of dexmedetomidine, 20 min: 20 minutes after the administration of dexmedetomidine, 30 min: 30 minutes after the administration of dexmedetomidine, Discharge: immediately before returning to the ward)

  • Fig. 2 A, B. Transitional changes in heart rate. Refer to Fig. 1 for the definition of the abbreviations.


Reference

1. Cormack JR, Orme RM, Costello TG. The role of alpha2-agonists in neurosurgery. J Clin Neurosci. 2005; 12:375–378. PMID: 15925765.
2. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology. 2000; 93:382–394. PMID: 10910487.
Article
3. Constantin JM, Momon A, Mantz J, Payen JF, De Jonghe B, Perbet S, et al. Efficacy and safety of sedation with dexmedetomidine in critical care patients: a meta-analysis of randomized controlled trials. Anaesth Crit Care Pain Med. 2016; 35:7–15. PMID: 26700947.
Article
4. Cillo JE Jr, Finn R. Hemodynamics in elderly coronary artery disease patients undergoing propofol sedation. J Oral Maxillofac Surg. 2006; 64:1338–1342. PMID: 16916666.
Article
5. Taguchi T, Fukuda K, Sekine H, Kakizawa T. Intravenous sedation and hemodynamic changes during dental implant surgery. Int J Oral Maxillofac Implants. 2011; 26:1303–1308. PMID: 22167437.
6. Hegde S, Padmanabha S, Bhat GK. A comparison of hemodynamic responses and patient comfort in catract surgery with and without midazolam as sedation. IOSR J Dent Med Sci. 2014; 13:23–27.
Article
7. Silva-Jr JM, Katayama HT, Nogueira FAM, Moura TB, Alves TL, de Oliveira BW. Comparison of dexmedetomidine and benzodiazepine for intraoperative sedation in elderly patients: a randomized clinical trial. Reg Anesth Pain Med. 2019; 44:319–324. PMID: 30777901.
Article
8. Kanto JH. Midazolam: the first water-soluble benzodiazepine. Pharmacology, pharmacokinetics and efficacy in insomnia and anesthesia. Pharmacotherapy. 1985; 5:138–155. PMID: 3161005.
Article
9. MacLaren R, Preslaski CR, Mueller SW, Kiser TH, Fish DN, Lavelle JC, et al. A randomized, double-blind pilot study of dexmedetomidine versus midazolam for intensive care unit sedation: patient recall of their experiences and short-term psychological outcomes. J Intensive Care Med. 2015; 30:167–175. PMID: 24227448.
10. Kunisawa T, Hanada S, Kurosawa A, Suzuki A, Takahata O, Iwasaki H. Dexmedetomidine was safely used for sedation during spinal anesthesia in a very elderly patient. J Anesth. 2010; 24:938–941. PMID: 21110048.
Article
11. Shah RR. Drug development and use in the elderly: search for the right dose and dosing regimen (Parts I and II). Br J Clin Pharmacol. 2004; 58:452–469. PMID: 15521892.
12. Ok HG, Baek SH, Baik SW, Kim HK, Shin SW, Kim KH. Optimal dose of dexmedetomidine for sedation during spinal anesthesia. Korean J Anesthesiol. 2013; 64:426–431. PMID: 23741565.
Article
13. Kim J, Kim WO, Kim HB, Kil HK. Adequate sedation with single-dose dexmedetomidine in patients undergoing transurethral resection of the prostate with spinal anaesthesia: a dose-response study by age group. BMC Anesthesiol. 2015; 15:17. PMID: 25971886.
Article
Full Text Links
  • JKAOMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr